Axonal membrane proteins are transported in distinct carriers: a two-color video microscopy study in cultured hippocampal neurons by Kaether, Christoph et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Axonal membrane proteins are transported in distinct carriers: a
two-color video microscopy study in cultured hippocampal
neurons
Citation for published version:
Kaether, C, Skehel, P & Dotti, CG 2000, 'Axonal membrane proteins are transported in distinct carriers: a
two-color video microscopy study in cultured hippocampal neurons' Molecular Biology of the Cell, vol. 11,
no. 4, pp. 1213-24. DOI: 10.1091/mbc.11.4.1213
Digital Object Identifier (DOI):
10.1091/mbc.11.4.1213
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Molecular Biology of the Cell
Publisher Rights Statement:
© 2000 by The American Society for Cell Biology
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
Molecular Biology of the Cell
Vol. 11, 1213–1224, April 2000
Axonal Membrane Proteins Are Transported in
Distinct Carriers: A Two-Color Video Microscopy
Study in Cultured Hippocampal NeuronshV
Christoph Kaether,* Paul Skehel,† and Carlos G. Dotti*‡
*European Molecular Biology Laboratory, Cell Biology Program, 69012 Heidelberg, Germany; and
†Division of Neurophysiology, National Institute for Medical Research, London NW7 1AA,
United Kingdom
Submitted October 21, 1999; Revised January 13, 2000; Accepted February 2, 2000
Monitoring Editor: Jennifer Lippincott-Schwartz
Neurons transport newly synthesized membrane proteins along axons by microtubule-mediated
fast axonal transport. Membrane proteins destined for different axonal subdomains are thought to
be transported in different transport carriers. To analyze this differential transport in living
neurons, we tagged the amyloid precursor protein (APP) and synaptophysin (p38) with green
fluorescent protein (GFP) variants. The resulting fusion proteins, APP-yellow fluorescent protein
(YFP), p38-enhanced GFP, and p38-enhanced cyan fluorescent protein, were expressed in hip-
pocampal neurons, and the cells were imaged by video microscopy. APP-YFP was transported in
elongated tubules that moved extremely fast (on average 4.5 mm/s) and over long distances. In
contrast, p38-enhanced GFP-transporting structures were more vesicular and moved four times
slower (0.9 mm/s) and over shorter distances only. Two-color video microscopy showed that the
two proteins were sorted to different carriers that moved with different characteristics along axons
of doubly transfected neurons. Antisense treatment using oligonucleotides against the kinesin
heavy chain slowed down the long, continuous movement of APP-YFP tubules and increased
frequency of directional changes. These results demonstrate for the first time directly the sorting
and transport of two axonal membrane proteins into different carriers. Moreover, the extremely
fast-moving tubules represent a previously unidentified type of axonal carrier.
INTRODUCTION
In neurons, newly synthesized proteins have to travel tre-
mendous distances to their final destinations. For proper
function and maintenance of both the elaborate dendritic
tree and the sometimes extremely elongated axon, neurons
need to have a fast and precise delivery system for newly
synthesized proteins. In recent years, many studies have led
to the identification of a variety of motor proteins and ac-
cessory molecules necessary for axonal transport. In fact, the
first molecular motor protein to be identified, kinesin, was
isolated from squid giant axons (Vale et al., 1985a) and chick
brain (Brady, 1985). Currently it is believed that there are a
number of different microtubule motor proteins, kinesin super-
family proteins (KIFs), each of which is responsible for a spe-
cific set of cargo (for review, see Hirokawa, 1997; Hirokawa et
al., 1998). KIF1A, for example, was shown to transport vesicles
containing a subset of synaptic vesicle proteins (Okada et al.,
1995; Yonekawa et al., 1998), whereas KIF2 transported a dis-
tinct class of vesicles (Noda et al., 1995).
According to this concept at least two sorting steps would
be needed: different axonal membrane proteins first are
segregated and packed into different carriers, presumably at
the level of the trans-Golgi network. These carriers are then
separated from those carriers destined for the somatoden-
dritic domain and transported into the axon. Therefore,
there might exist several different axonal sorting signals, for
the sorting into distinct carriers and for subsequent axonal
targeting. Interestingly, no conserved axonal sorting signal
has been described to date (Winckler and Mellman, 1999).
The amyloid precursor protein (APP) is an ubiquitously
expressed type I transmembrane protein of unknown func-
tion. A small cleavage product of APP, Ab, is the principle
hV Online version of this article contains video material for Fig-
ures 4, 5, 8, and 9. Online version available at www.molbiol-
cell.org.
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constituent of the amyloid plaques in the brains of Alzhei-
mer’s disease patients (for review, see Selkoe, 1999). In neu-
rons, newly synthesized APP is targeted to the axon and
subsequently transcytosed to the somatodendritic domain
(Simons et al., 1995; Yamazaki et al., 1995). Radioactive la-
beling studies suggested that APP is transported into the
axon by fast axonal transport (Koo et al., 1990) dependent on
conventional kinesin (Amaratunga et al., 1993; Ferreira et al.,
1993; Buxbaum et al., 1998). In the amyloidogenic pathway,
APP cleavage leads to the production of Ab, or, more abun-
dantly, cleavage in the nonamyloidogenic pathway leads to
a soluble APP and a membrane-bound C-terminal fragment.
Cleavage in the amyloidogenic pathway is mediated by b-
and g-secretase and in the nonamyloidogenic pathway by
a-secretase (summarized by Hardy, 1997; Selkoe, 1999). De-
spite numerous efforts, the molecular identities of the secre-
tases have not yet been fully established. For a better under-
standing of the mechanisms that govern APP processing in
neurons, it appears essential to precisely characterize the
subcellular localization of APP at any given stage of its short
lifetime, calculated to be 20–30 min, in PC12 cells and neu-
rons (Weidemann et al., 1989; Storey et al., 1999).
We therefore decided to follow the fate of newly synthe-
sized APP directly in living cultured hippocampal neurons
and to characterize its mode of transport. Hippocampal
neurons have been used extensively as a model system of
transport and protein sorting (Craig and Banker, 1994).
Moreover, the hippocampus is one of the predominantly
affected regions in Alzheimer’s disease (Selkoe, 1999). There-
fore, hippocampal neuronal cultures are a particularly use-
ful and relevant system with which to study APP trafficking
and transport.
In the present study we expressed a fluorescent protein
(FP)-tagged APP in hippocampal neurons and analyzed its
transport by video microscopy. FP-tagged APP moves along
axons in very fast-moving elongated tubules, which have
not been described previously. We show by two-color video
microscopy that these tubules are different from the trans-
port carriers of another axonal membrane protein, synapto-
physin (p38).
MATERIALS AND METHODS
Antibodies
For detection of APP we used monoclonal antibody 22C11 (Roche
Diagnostics, Mannheim, Germany); for detection of green fluores-
cent protein (GFP) we used a polyclonal antibody from Clontech
Laboratories (Palo Alto, CA) and a polyclonal antibody raised
against the C terminus (D2; Wacker et al., 1997), kindly provided by
Dr. H.-H. Gerdes (Department of Neurobiology, University Heidel-
berg, Heidelberg, Germany). To stain dendrites we used a mono-
clonal anti-MAP2 antibody (Sigma, Deisenhofen, Germany).
Construction of Fusion Proteins
APP-Yellow Fluorescent Protein (YFP). Standard molecular clon-
ing techniques were used throughout. YFP5 cDNA (Pepperkok et
al., 1999) without the start codon was fused to the 39end of human
APP695 cDNA omitting the stop codon. The introduction of the
restriction site, NotI, resulted in a linker sequence coding for
three alanines. YFP5 was amplified with PCR using primer
59-GCGCGCGGCCGCGGGTAAAGGAGAAGAACTTTTC, intro-
ducing a NotI site (underlined), and primer 59-GCGCGGGC-
CCTAGAAGCTTTTGTATAGTTC, introducing ApaI. The obtained
fragment was subcloned using the TOPO-TA cloning kit (Invitro-
gen, Groningen, The Netherlands), and the resulting plasmid,
pCR-TOPO/YFP, was digested with NotI and ApaI. The YFP
fragment was purified and then subcloned in pcDNA3 (Invitro-
gen), yielding pcDNA3/YFP. APP was amplified from pSG5-
hAPP695 (kindly provided by B. de Strooper, Center for Human
Genetics, Leuven, Belgium) using primer 59-GCGCGATATC-
G C C A C CATGCTGCCCGGTTTGGCACTGCTC, introducing EcoRV
(underlined) and a Kosak sequence (dashed line), and primer 59-
GCGCGCGGCCGCGTTCTGCATCTGCTCAAAGAACTTG, intro-
ducing NotI (underlined). The fragment was cloned in pCR-TOPO,
digested with EcoRV and NotI, and subcloned in pcDNA3/YFP to
obtain pcDNA3/APP-YFP. Relevant parts including the Ab-do-
main, the transmembrane and cytoplasmic domains of APP, as well
as the transition site of the construct were sequenced.
p38-Enhanced GFP (EGFP) and p38-Enhanced Cyan Fluorescent
Protein (ECFP). A plasmid encoding for a GFP-tagged p38 was
constructed by amplifying rat p38 cDNA (Leube et al., 1987) using
primer 59-CTGCAAGCTTCGGACATGGACGTGGTG, introducing
HindIII (underlined) and primer 59-GACCGTCGACCATCTGATT-
GGAGAAGG, introducing SalI (underlined) and replacing the stop
codon with a valine codon. The purified fragment was HindIII and
SalI digested and cloned in pEGFP-N3 (Clontech). The construct
was sequenced, and a point mutation was found, changing codon
185 from C to R, apparently without observable effects, because a
construct with a reversed mutation behaved very similar (our un-
published results). Moreover, the dynamics are very similar to
another p38-GFP construct (Nakata et al., 1998).
For p38-ECFP the p38 cDNA was amplified from p38-EGFP using
the primer 59-AAGCTTGCCACCATGGACGTGGTGAATCAG,
covering the HindIII site (underlined), and the primer 59-GTCGA-
CACCATCTGATTGGAGAAGGAG, using the SalI site (under-
lined). After subcloning in pCR-TOPO, digestion with HindIII–SalI,
and gel purification, the fragment was subcloned in pECFP-N1
(Clontech).
Cell Culture and Transient Transfection
Cultures of embryonic day 18 rat embryonic hippocampal neurons
were prepared as described (de Hoop et al., 1998). Neurons were
transfected at days 6–8 in vitro, corresponding to stage 4 neurons
(Dotti et al., 1988). For transfection, a calcium phosphate precipita-
tion protocol was used (Ko¨hrmann et al., 1999). Neurons grown on
15-mm coverslips were transferred to 3.5-cm dishes containing 2 ml
of conditioned medium. Alternatively, the medium of neurons
grown on poly-l-lysine–coated 3.5-cm dishes was replaced with
conditioned medium. Two to 3 mg of endotoxin-free (EndoFree
Maxi Prep; Qiagen, Hilden, Germany) plasmid DNA were dis-
solved in 60 ml of 250 mM CaCl2. A 23 concentration of BBS (280
mM NaCl, 1.5 mM Na2HPO4, and 50 mM N,N-bis[2-hydroxyethyl]-
2-aminoethanesulfonic acid, pH 7.05) was added slowly, and the
precipitate was allowed to form for 1 min. This solution was added
to the cells, and the dishes were incubated for 1–2 h at 37°C and
2.5% CO2. Cells were then washed twice in HBS (135 mM NaCl, 20
mM HEPES, 4 mM KCl, 1 mM Na2HPO4, 2 mM CaCl2, 1 mM MgCl,
and 10 mM glucose, pH 7.05) before the original growth medium
was added. Double transfections were done by preparing the trans-
fection mix with the two plasmids, each at the concentration used
for single transfections. Analysis of transfected cells was performed
24–28 h after the transfection. Typically 1–20% of neurons were
transfected. Some neurons expressed very high amounts of exoge-
nous proteins resulting in uniform green fluorescence. For micros-
copy only neurons that showed punctate fluorescence and no bead-
ing along neurites were chosen.
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Immunodetection
Immunofluorescence was performed as described (Wacker et al.,
1997). We found that APP-YFP fluorescence was not preserved after
fixation in 4% paraformaldehyde. For immunoblotting, neurons
were grown on 3.5-cm dishes covered with a sterile coverslip. After
transfection, 2 mM sodium butyrate was added to the medium
(Stowell and Craig, 1999). Sixteen to 20 h after transfection, media of
three dishes were pooled, and proteins were precipitated by adding
4 vol of acetone in the presence of BSA as a carrier. After 2 h at
220°C, samples were centrifuged, and the pellet was air dried and
dissolved in running buffer. Corresponding cells were lysed in 0.1%
SDS and methanol-chloroform extracted (Wessel and Flu¨gge, 1984).
Lysates and media were run on a 10% minigel (Bio-Rad, Hercules,
CA) and blotted onto nitrocellulose. Western blotting was per-
formed as described previously (Wacker et al., 1997).
Rhodamine-Dextran Uptake
Endocytic organelles were labeled by incubation of neurons for 1–2
h in conditioned medium supplemented with 1 mg/ml rhodamine-
dextran (Rh-dextran), molecular weight 70,000 (Sigma). Before mi-
croscopy, cells were washed in HBS and conditioned medium.
Antisense Treatment
Antisense experiments were done as previously described by Fer-
reira et al. (1992). Oligonucleotides used were GCCGGGTCCGC-
CATCTTTCTGGCAG, the inverse complement of the rat nucleo-
tides 211 to 1 14 of conventional kinesin heavy chain (KHC), and
CTGCCAGAAAGATGGCGGACCCGGC, the corresponding sense
oligonucleotide (Ferreira et al., 1992). Five to 6 h later transfection
oligos were added at a concentration of 0.5 mM. Twelve hours later
oligos were added at a concentration of 0.25 mM. Video microscopy
was performed 26–28 h after transfection. Treating cells with oligos
at 50 mM (Ferreira et al., 1992) led to similar results, except that even
more structures changed direction of movement (our unpublished
results).
Microscopy
Fixed cells were analyzed on a Zeiss (Thornwood, NY) Axiovert
microscope equipped with a 40 or 633 objective using standard
FITC and rhodamine filters. Images were collected with a Cohu (San
Diego, CA) camera controlled by NIH Image software, combined,
and processed using Photoshop (Adobe Systems, Mountain View,
CA). Staining in neurites was selectively enhanced over cell bodies.
For live cell imaging of transfected neurons, coverslips were
transferred to aluminum slides (Bradke and Dotti, 1997). Two video
microscopy setups were used. Initial experiments and antisense
experiments were performed on a Zeiss Axiovert microscope with
an 37°C-heated, 633, numerical aperture 1.4 objective, a standard
FITC filter (BP485, FT510, LP520; Zeiss), a Blitz Optilas (Puchheim,
Germany) shutter, a Cohu camera, and NIH image software (Bradke
and Dotti, 1997). Time-lapse series for velocity determination as
well as analysis of double transfected neurons were done on a Leica
(Nussloch, Germany) DM IRBE equipped with a custom-made
Plexiglas box for air heating to 37°C, a 633 objective, a Hamamatsu
C 4742 camera (Hamamatsu Photonics, Herrsching, Germany), and
OpenLab software (Improvision, Boston, MA; Toomre et al., 1999).
To image YFP and CFP separately, appropriate filter blocks were
used (AHF Analysentechnik, Tu¨bingen, Germany). Excitation light
was attenuated with gray filters. Typically, time-lapse series were
taken without delay at exposure times between 300 and 800 ms per
frame. Tubular appearance attributable to movement during expo-
sure time could account only for a maximal length of 5 mm (calcu-
lated for 1-s exposure time; average velocity, 5 mm/s), not for the
10-mm tubules observed frequently with exposure times down to
300 ms. For dual-color imaging the following setups were used. YFP
and CFP were excited separately with filters (AHF) on a filter wheel.
For emission, a custom-made dual beam splitter was used (AHF,
blocking at 390/22, 436/10, and 515/10–15 nm). Exposure time for
CFP was 110 ms and for YFP was 1 s. GFP and Rh-dextran were
excited with filters for FITC and TRITC, respectively, and the emis-
sion was recorded using a dual beam splitter for FITC and TRITC.
Exposure times were 1 s for GFP and 700 ms for Rh-dextran. Twenty
pairs of images were recorded in 60 s. Neurons were very sensitive
to CFP excitation; therefore, only series of up to 20 images could be
recorded before movement of all organelles stopped.
Tracking
For particle tracking an NIH Image-based manual macro written by
J. Rietdorf (European Molecular Biology Laboratory) was used.
Stacks of time-lapse sequences were analyzed for movement of
fluorescent structures. Only structures moving over more than three
frames were evaluated. The pixel size was determined using a stage
micrometer (Graticules, Tonbridge, United Kingdom), and the ac-
tual time the system needed for recording of a time-lapse series was
measured. This allowed the time between subsequent frames and
the distance that a tracked structure moved to be calculated. From
the data, the maximal and average velocity and the displacement of
fluorescent structures were calculated.
RESULTS
Construction of GFP Fusion Proteins
The aim of our study was to analyze the trafficking of APP
in living neurons and compare it with the trafficking of
another axonal membrane protein, the synaptic vesicle pro-
tein p38. Therefore, we tagged the human APP695 at the C
terminus with a spectral variant of GFP, YFP5 (Pepperkok et
al., 1999). Two other fusion proteins, consisting of p38 and
EGFP (p38-EGFP) and p38 and another spectral GFP variant,
ECFP (p38-ECFP), were constructed. The YFP/CFP mutants
were chosen to allow simultaneous visualization of two
different proteins in a single cell (Ellenberg et al., 1999). The
fusion proteins are schematized in Figure 1.
Figure 1. Schematic diagram of GFP fusion proteins.YFP was
fused to the C terminus of human APP695 (left). EGFP and ECFP
were fused to the C terminus of rat p38 (right). In both constructs
the FP is in the cytoplasm. The double line represents the plasma
membrane.
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FP-tagged Fusion Proteins Are Expressed as Full-
Length Proteins and Sorted to Axons in
Hippocampal Neurons
Before analyzing the transport of the fusion proteins by
video microscopy, we ensured that the proteins were ex-
pressed as full-length proteins and that they were correctly
localized. This was especially important in the case of APP-
YFP, because the APP is subject to a variety of potential
proteolytic cleavages. For example, extensive intracellular a-
or b-secretase cleavage would generate an FP-tagged cyto-
plasmic tail and transmembrane domain of APP indistin-
guishable from intact protein by fluorescent microscopy. To
check for full-length expression, hippocampal neurons were
transfected with APP-YFP cDNA and analyzed by Western
blot. Using a GFP-specific antibody, a prominent band with
the size of the fusion protein (130 kDa) was detected in cell
lysates of transfected cells (Figure 2A, left). As expected for
a transmembrane protein, no signal was detected in the
medium. Only a minor degradation product is visible in the
cell lysate of transfected neurons (Figure 2A, arrow). To
substantiate this finding, the blot was stripped and reprobed
with an APP-specific antibody (Figure 2A, right). The anti-
body detected full-length APP-YFP as well as endogenous
rat APP. If a significant amount of APP-YFP would be
cleaved by a-secretase, one would expect more of the solu-
ble APP fragment in the medium of transfected cells com-
pared with control cells. This is not the case (Figure 2A,
right). Similarly, cell lysates of neurons transfected with
p38-EGFP cDNA show only the full-length fusion protein
when probed with an antibody against GFP (Figure 2B). The
minor lower band reflects unspecific cross-reaction of the
antibody (Figure 2B, asterisk).
Because we wanted to study axonal transport, we next
analyzed whether the fusion proteins would be sorted to
axons after transient transfection. Therefore, neurons cul-
tured for 6–9 d were transfected with APP-YFP and p38-
EGFP cDNA, respectively, and subjected to immunofluores-
cence using antibodies against GFP and MAP2, a marker for
dendrites. Microscopic analysis of both constructs showed
that they were sorted to axons as expected (Figure 3). In
addition, a somatodendritic staining was observed for both
constructs. This has been found for a variety of exogenously
expressed axonal and apical proteins and could be due to
saturation of the axonal sorting machinery (reviewed by
Winckler and Mellman, 1999). In the case of APP-YFP a
somatodendritic localization of at least some of the protein
could be due to transcytosis from the axon (Simons et al.,
1995; Yamazaki et al., 1995).
Taken together, these data suggest that APP-YFP and
p38-EGFP are useful markers to study axonal transport in
living hippocampal neurons.
APP-YFP Is Transported along Axons in Elongated,
Fast-moving Tubules
To visualize the transport of APP-YFP in the axons of living
hippocampal neurons, we transfected cells with APP-YFP
cDNA and analyzed the transport at 37°C by video micros-
copy. Typically, 24 h after transfection, expression of exog-
enous proteins could be observed in 1–20% of neurons.
Transfected cells that appeared healthy by phase-contrast
and GFP fluorescence were imaged by video microscopy.
Figure 4 (video) shows six consecutive frames (0.9 s apart) of
a time-lapse sequence collected from axons of transfected
neurons. Long tubular structures were moving along the
axons, mainly anterogradely (Figure 4, arrows) but occasion-
ally retrogradely (Figure 4, arrowheads). In addition to the
moving tubules, stationary or slow moving vesicles were
present (Figure 4, asterisk). The tubular appearance of the
transport carriers was not due to an artifact created by the
movement of a structure during exposure time (see MATE-
RIALS AND METHODS) or due to overexpression, because
tubules were observed also in neurons expressing very low
amounts of APP-YFP. The tubules were of variable length
and could be as long as 10 mm. The length of a tubule was
not correlated to its speed. Occasionally a tubule could be
seen to stop, without losing the tubular appearance, then
eventually shrinking to a vesicle before elongating again and
resuming movement (our unpublished results). The tubules
are not mitochondria, which also show a tubular appearance
in axons (Morris and Hollenbeck, 1995), as shown by stain-
ing with rhodamine 123 (our unpublished results). Only in
very few cases did the APP-YFP tubules change direction;
in many cases they transversed the field of view without
stopping.
To quantitate these movements, axonal transport in a
number of transfected neurons was recorded. Evaluation of
8 cells from three different experiments showed that of 156
clearly discernible structures 32% (50 particles, all vesicular)
did not move or only moved over a short distance (,3 mm).
Forty-eight percent (75) moved anterogradely over long dis-
tances, 97.3% (73) of which were long tubules and 2.7% (2) of
which were vesicular. The remaining 20% (31) were moving
retrogradely, 71% (22) of which were tubular, the others
vesicular.
We next tracked all structures moving .3 mm and calcu-
lated their velocity. APP-YFP–containing transport carriers
Figure 2. Transfected GFP fusion proteins are expressed as full-
length proteins. (A) Cell lysates (C) and media (M) of 8-d-old
APP-YFP–transfected (1) and mock-transfected (2) neurons were
analyzed by SDS-PAGE and immunoblotting with GFP antiserum
(aGFP). The asterisk marks a nonspecific band visible in transfected
and control neurons; the arrow points to a minor degradation band.
After stripping, the blot was reprobed with an antibody against APP
(aAPP). Full-length APP-YFP as well as endogenous rat APP were
detected. Molecular mass markers are indicated in kilodaltons (B)
Cell lysates of 9-d-old p38-EGFP–transfected (1) and mock-trans-
fected (2) neurons were analyzed by SDS-PAGE and immunoblot-
ting with GFP antiserum D2 (aGFP). The asterisk marks a promi-
nent nonspecific band. Molecular mass markers are indicated in
kilodaltons.
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were moving anterogradely at an average velocity of 4.5 6
1.5 mm/s with maximal velocities of up to 9 mm/s. Retro-
gradely APP-YFP–containing structures moved slower, on
average 2.9 6 1 mm/s. Transport carriers could be followed
on average for 53 mm before leaving the field of view or
plane of focus or, rarely observed, stopping.
p38-EGFP Is Transported in Different Carriers
Are other axonal membrane proteins also transported in
elongated tubules? To test this, neurons were transfected
with p38-EGFP cDNA and analyzed by video microscopy
(Figure 5, video). Fluorescent vesicles could be observed
along the axons of transfected cells. They showed two types
of movement: bright fluorescent vesicles without movement
or moving over short distances (Figure 5, arrowheads) and
tubulovesicular structures, often less bright, moving either
anterogradely or retrogradely (Figure 5, arrows). The overall
appearance, however, was strikingly different compared
with the movement of APP-YFP carriers. No tubules or only
short ones could be observed, and carriers rarely moved
over long distances (Figure 5). The dynamics of p38-EGFP–
labeled organelles are reminiscent of those of recycling en-
dosomes recently described by Prekeris et al., (1999). We
therefore tested to what extent the p38-EGFP–containing
organelles could be labeled with an endosomal marker. To
this end, we labeled p38-EGFP–transfected neurons with
Rh-dextran and analyzed them by two-color video micros-
copy (Figure 6). Moving p38-EGFP–labeled tubulovesicular
structures were not costained with the endosomal marker,
suggesting that they are transport vesicles rather than endo-
somes (Figure 6, arrowheads). Moving Rh-dextran–labeled
organelles were often devoid of p38-EGFP staining (Figure
6, arrows). However, we sometimes observed moving struc-
tures containing both p38-EGFP and Rh-dextran (our un-
published results). In addition to the moving organelles,
many immobile short tubulovesicular organelles containing
both markers were observed (Figure 6, asterisks). Taken
together, these data suggest that the organelles labeled by
p38-EGFP are a mixture of endocytic and exocytic vesicles.
To quantify the movement of p38-EGFP fluorescent
transport carriers, time-lapse microscopy of transfected
neurons was analyzed as for APP-YFP. From eight cells
from three independent experiments, 165 clearly discern-
able fluorescent carriers were tracked. Fifty-six percent
(92) of p38-EGFP– containing carriers were not moving or
showed brownian motion. These most likely corre-
sponded to organelles of endocytic origin. Forty-four per-
cent (73) showed movement over .3 mm, without direc-
tional bias. The average velocity of anterogradely moving
carriers was 0.9 6 0.9 mm/s, more than four times slower
than APP-YFP– containing carriers. Retrogradely moving
Figure 3. GFP-labeled fusion proteins are sorted to axons. Seven- to 10-d-old neurons were transfected with APP-YFP (A and B) or
p38-EGFP (C and D) cDNA, fixed after 1 d, and processed for immunofluorescence using anti-GFP antiserum (aGFP) and anti-MAP2
monoclonal antibody (aMAP2). Arrows indicate axons as defined by the absence of MAP2 labeling. Bar, 10 mm.
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carriers were slightly faster, on average 1.2 6 1.2 mm/s.
p38-EGFP moving structures could be tracked on average
only 6.6 mm, eight times shorter than APP-YFP– contain-
ing tubules. A comparable p38-GFP has been shown to
move in a similar manner in dorsal root ganglion neurons
(Nakata et al., 1998). Because all p38-EGFP–labeled or-
ganelles, endosomes and transport vesicles, move with
dynamics strikingly different from those labeled with
APP-YFP, these data suggest that the two proteins are
transported in different carriers. A velocity profile of APP-
YFP– and p38-EGFP– containing carriers is shown in Fig-
ure 7, and the findings are summarized in Table 1.
In Doubly Transfected Neurons, APP-YFP and p38-
ECFP Are Transported in Different Carriers
APP-YFP and p38-EGFP transport carriers move in a strik-
ingly different manner along axons, suggesting that they are
sorted to different transport carriers. To directly analyze the
sorting and differential transport of the two proteins in
single axons, we cotransfected neurons with both APP-YFP
and p38-ECFP cDNAs. Most transfected cells expressed both
exogenous proteins, however, often in differing amounts.
Neurons expressing approximately similar amounts of both
proteins were chosen and analyzed by two-color video mi-
croscopy (Figure 8). When frames of either the YFP or CFP
channel were displayed separately, they looked identical to
the single transfected neurons: APP-YFP moving in long
tubules (Figure 8A, left, video), p38-ECFP moving slower
and in vesicular structures (Figure 8A, middle, video). Dis-
play of the merged frames shows the different movement of
the two proteins along the same axon (Figure 8A, right,
video). The long tubules transporting APP-YFP did not con-
tain p38-ECFP (Figure 8B, arrows). Conversely, moving p38-
ECFP–containing structures did not appear to have APP-
Figure 4. APP-YFP is transported in long tubules along axons (video). Nine-day-old neurons were transfected with APP-YFP cDNA and
analyzed 24 h later by video microscopy. Frames were taken every 0.9 s; 6 subsequent frames of 50 frames (total length, 45 s) are shown.
Arrows depict fast anterogradely moving, APP-YFP–containing tubules; arrowheads indicate retrogradely moving tubules. The asterisk
points to nonmoving, vesicular structures. Bar. 10 mm.
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YFP (Figure 8B, triangle). Occasionally, slow or nonmoving
structures containing both proteins were seen, which are
possibly endosomes or multivesicular bodies (Figure 8B,
arrowheads), because slow-moving, nontubular APP-YFP
carriers can be labeled with Rh-transferrin (our unpublished
results).
Taken together these data suggest that FP-tagged APP
and p38 are sorted to and transported in carriers that differ
in their morphology, their velocity, and their displacement.
This implies that these carriers have a different molecular
composition and are transported by the action of different
motor proteins.
APP-YFP Transport Is Kinesin Dependent
Treatment of hippocampal neurons with antisense oligonu-
cleotides against KHC and subsequent immunofluorescence
suggested a role for kinesin in the fast axonal transport of
APP (Ferreira et al., 1993; Yamazaki et al., 1995). To test the
effect of kinesin on the transport of the APP-YFP tubules
described here, we treated transfected neurons with KHC
antisense or sense oligonucleotides. The transport of APP-
YFP was then analyzed by video microscopy (Figure 9,
video). In transfected neurons treated with sense oligonu-
cleotides, the previously observed pattern of movement was
observed: tubules moving over long distances and almost
never changing their direction during recording of 30–70
frames (Figure 9, left, the track display of one structure is
shown). In contrast, APP-YFP tubules showed a different
type of movement when neurons were treated with anti-
sense oligonucleotides: The shape of the tubules was un-
changed, but their velocity was reduced. In addition, many
of the observed moving structures changed their direction of
Figure 5. p38-EGFP is transported
in tubulovesicular structures (video).
Seven- to 8-d-old neurons were
transfected with p38-EGFP cDNA
and analyzed 24 h later by video mi-
croscopy. Frames were taken every
3 s; two subsequent frames of 70 (to-
tal length, 210 s) are shown. White
arrows depict moving, p38-EGFP–
containing tubules; gray arrows indi-
cate the positions of the structures in
the previous frame. Arrowheads
point to nonmoving structures. Top,
anterograde. Bar, 10 mm.
Figure 6. Moving p38-EGFP–con-
taining vesicles do not contain an en-
dosomal marker. Eight-day-old neu-
rons were transfected with p38-
EGFP cDNA, labeled 22 h later for
1–2 h with 1 mg/ml Rh-dextran, and
analyzed by two-color video micros-
copy as described in MATERIALS
AND METHODS. Top, consecutive
frames showing p38-EGFP-fluores-
cence; bottom, corresponding frames
showing Rh-dextran fluorescence.
Arrowheads point to moving p38-
EGFP–containing vesicles; arrows
point to a moving Rh-dextran–con-
taining vesicle. Asterisks mark non-
moving structures that contain both
markes. Note that moving vesicles
contain one marker only. Bar, 10 mm.
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movement several times (exemplified in Figure 9, right, where
the tubule changed direction four times). Quantitation of 28
cells from four experiments showed that the velocity of APP-
YFP tubules in antisense-treated neurons was on average re-
duced to 60% of the control velocity, and that 19 of 66 (29%) of
the observed tubules changed their direction at least once,
compared with 3% in control neurons. Interestingly, both an-
terograde and retrograde transport were affected, similar to
observations in squid axons (Brady et al., 1990). These data
demonstrate that the transport of APP-YFP tubules is microtu-
bule and kinesin dependent.
DISCUSSION
In this study we show that a fluorescently tagged APP,
APP-YFP, is transported in extended, very fast-moving tu-
bules along axons of cultured hippocampal neurons. In con-
trast, another axonal protein, p38, is sorted to and trans-
ported in different structures when expressed as an FP-
tagged fusion protein. The two transport carriers were
shown to be different by video microscopy and object track-
ing. Major differences were 1) morphology; whereas APP-
YFP was transported in fast-moving tubules of up to 10 mm
length, p38-EGFP was transported in tubulovesicular carri-
ers; 2) velocity; APP-YFP tubules moved on average 4.5
mm/s, more than fourfold faster than structures containing
p38-EGFP; and 3) mutual exclusion; fast-moving APP-YFP
tubules contained no p38-ECFP when coexpressed in the
same neuron and analyzed by two-color video microscopy.
The elongated, fast-moving tubules represent a previously
undescribed type of transport carrier for membrane proteins.
Shorter and slower moving tubulovesicular post-Golgi struc-
tures have been described in neurons (Nakata et al., 1998) and
unpolarized cells (Hirschberg et al., 1998; Toomre et al., 1999).
Axonal transport in different systems was reported to be be-
tween 1 and 3 mm/s on average, sometimes with maximal
velocities of up to 5 mm/s (Allen et al., 1982; Kreis et al., 1989;
Bloom et al., 1993; Lochner et al., 1998; Nakata et al., 1998;
Zakharenko and Popov, 1998; Bridgman, 1999). The velocity
measured for APP-YFP in our system is in the range of the fast
component of fast axonal transport in mammals in vivo, which
has been calculated to have a velocity of 410 mm/d (Ochs,
1972), corresponding to 4.7 mm/s.
The concept of separate transport carriers for subclasses of
axonal membrane proteins has been proposed by Hirokawa
et al. (1998). We confirm this concept by comparing the
transport characteristics of two axonal membrane proteins
and the direct observation of their differential transport in a
single hippocampal neuron. To our knowledge this is the
first report in which this sorting and transport of two axonal
Figure 7. Velocity profile of axonal transport of APP-YFP in com-
parison with p38-EGFP. Neurons were transfected with APP-YFP
and p38-EGFP cDNA, respectively, and analyzed by video micros-
copy. Moving structures were tracked, and the velocity was calcu-
lated as described in MATERIALS AND METHODS. (A) Velocity
profile of APP-YFP–containing moving structures. (B) Velocity pro-
file of p38-EGFP–containing moving structures. Measurements,
number of measured velocities between two frames.
Table 1. Characteristics of FP-tagged APP and p38
APP-YFP
p38-EGFP
(this study)
p38 GFP
(Nakata et al., 1998)
Morphology Mainly tubular Mainly vesicular Tubulovesicular
Direction Mainly anterograde Anterograde and retrograde Anterograde and retrograde
Average velocity (mm/s) 4.5 6 1.5 (anterograde) 0.9 6 0.9 (anterograde) 0.69 6 0.33
2.9 6 1 (retrograde) 1.2 6 1.2 (retrograde)
Maximal velocity (mm/s) 8–9 5 ND
Displacement (mm) 53.7 (n 5 32) 6.6 (n 5 34) ND
Average velocities were determined of all measurements; the displacement is the average distance a moving structure could be tracked until
it left the field of view, stopped moving, or became indistinguishable from other fluorescent structures. ND, not determined. Data on p38-GFP
were taken from Nakata et al. (1998).
C. Kaether et al.
Molecular Biology of the Cell1220
proteins is visualized simultaneously. The observed differ-
ence in velocities between the two types of carriers in the
same neuron is consistent with the idea that the transport is
mediated by different motor proteins (Hirokawa, 1998).
Why Is There No Bias in the Transport of
p38-EGFP?
In steady state, p38-EGFP is distributed along the axon.
Therefore, a net anterograde transport of newly synthesized
protein would be expected, which is not observed in our
system. Because both endosomes and transport carriers
show movement in both directions (Nakata et al., 1998; Prek-
eris et al., 1999), and because p38-EGFP is present in both
types of organelles (Nakata et al., 1998; this study), it is
possible that a net anterograde movement of p38-EGFP
transport vesicles is masked. Therefore, even a slight net
anterograde movement that is not detectable in our system
could still account for the distribution of p38-EGFP–labeled
Figure 8. Two-color video microscopy of doubly transfected neurons shows little colocalization of APP-YFP and p38-ECFP (video). Seven- to
8-d-old neurons were doubly transfected with APP-YFP and p38-ECFP cDNA, and two-color video microscopy was performed as described in
MATERIALS AND METHODS. (A), Left, frames showing APP-YFP (video); middle, frames showing p38-EGFP (video); right, merged images
(video). APP-YFP is shown in green; p38-ECFP is shown in red. (B) Five subsequent frames from the boxed area in A are displayed separately. Top
row, APP-YFP; bottom row, p38-ECFP. Arrows mark the position of a fast-moving APP-YFP–positive, p38-ECFP–negative tubule; arrowheads
mark the position of a retrogradely moving vesicular structure containing both proteins. The triangle marks the position of a p38-ECFP–positive,
APP-YFP–negative structure moving to the right of the image. The total number of frames is 20 pairs, recorded during 64 s. Bar, 10 mm.
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organelles along the axon, because there is sufficient time for
equilibration between transfection and microscopy.
What Defines the Structure of the APP-YFP
Tubules?
The axon is packed with cytoskeletal elements, transport
carriers moving in both directions, mitochondria, and other
organelles. Elongation of big vesicles might be a conse-
quence of dragging this vesicle through a dense network.
Indeed, mitochondria in axons are also very thin and elon-
gated (Morris and Hollenbeck, 1995). Moreover, we occa-
sionally observed APP-YFP tubules that rounded up shortly
after stopping (our unpublished results). APP-YFP–contain-
ing carriers could be bigger than those containing p38-EGFP;
therefore, they could be more subjected to mechanical stress
and be forced into a tubular shape. Alternatively, the two
carriers could be of different rigidity because of differences
in lipid and protein composition, therefore responding dif-
ferently to the mechanical forces they encounter when
squeezed through the dense axonal cytoplasm. When the
GFP fusion proteins were expressed in COS cells, we could
detect tubules only in the APP-YFP–transfected cells, not in
p38-EGFP–transfected cells (our unpublished results). This
suggests that also in unpolarized cells they are sorted into
distinct carriers that differ in their composition.
How Is the Velocity Accomplished?
It has been suggested that in axons the size of an organelle
determines its velocity, smaller objects moving faster than
bigger ones (Vale et al., 1985b). In our case we observed the
opposite: long tubules containing APP-YFP moved much
faster than the smaller tubulovesicular structures containing
p38-EGFP. The fast movement might reflect a joint effort of
the molecular motors that are attached to the tubules, lead-
ing to a higher velocity, as would be the case for single or
few motors only. The fact that many motors are attached to
a tubule might also explain why the movement is smooth
and continuous over long distances, in contrast to the typical
saltatory movement observed for axonal transport.
Reducing kinesin expression disturbs the transport of
APP-YFP carriers. Upon reduction of kinesin, a lower veloc-
ity as well as a frequent change of direction were observed.
Studies using squid axonal vesicles suggested that there are
plus end- as well as minus end-directed motor proteins
present and that the ratio between the two determines the
direction of movement (Muresan et al., 1996). A similar
scenario could be envisioned for mammalian neurons: on
APP-YFP–containing tubules both plus end- and minus
end-directed motors are present; however, kinesin is domi-
nating. This leads to long-distance movement in one direc-
tion only. Treatment of neurons with kinesin antisense oli-
gonucleotides would interfere with this ratio, driving it to a
more equilibrated state. This would lead to the frequent
change of direction observed in antisense treated neurons. It
would be interesting to test the effects of the antisense treat-
ment on the transport of p38-EGFP. However, because of the
small-distance movement and the low velocities of p38-
EGFP–containing structures, no significant effect was mea-
sured using our setup (C. Kaether and C.G. Dotti, unpub-
lished results). Faster image acquisition together with higher
sensitivity would be needed to study this process.
Figure 9. KHC antisense treatment interferes with axonal trans-
port of APP-YFP (video). Seven- to 8-d-old neurons were trans-
fected with APP-YFP and incubated overnight with sense (s) and
antisense (as) oligonucleotides corresponding to KHC. Video mi-
croscopy was performed, and tracks were analyzed. Every second
frame of eight frames and the corresponding track displays are
shown for both conditions. Top, anterograde. Total length: sense, 34
frames recorded in 44 s; antisense, 71 frames recorded in 123 s. Bar,
10 mm.
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Implications on APP Processing
Of principal interest in Alzheimer’s disease research is to
determine the subcellular localization of APP processing
and hence the localization of the different secretases. Precise
kinetic studies on Ab production in neurons are lacking.
These are complicated by the fact that they are highly po-
larized: processing in intracellular organelles could take
place in the soma, in the dendrites, or in the axon, or pro-
cessing could take place at the plasma membranes of one or
more of these domains. Our studies help provide tools for a
detailed analysis of APP processing in neurons: correlation
of the transport kinetics using APP-YFP and video micros-
copy together with pulse–chase labeling to monitor the pro-
cessing state could help provide information about the sub-
cellular identity of the cleavage compartment in neurons.
ACKNOWLEDGMENTS
We thank B. Hellias for preparing hippocampal cultures, H.-H.
Gerdes for kindly providing antiserum D2, B. de Strooper for
APP695 cDNA, R. Pepperkok for YFP5 cDNA, and J. Rietdorf for
writing the tracking macro. We also thank M. Hannah, M. Kiebler,
D. Toomre, F. Ruberti, and E. Piddini for critically reading the
manuscript. C.K. is a recipient of a fellowship from the Fritz-Thyssen-
Stiftung.
REFERENCES
Allen, R.D., Metuzals, J., Tasaki, I., Brady, S.T., and Gilbert, S.P.
(1982). Fast axonal transport in squid giant axon. Science 218, 1127–
1129.
Amaratunga, A., Morin, P.J., Kosik, K.S., and Fine, R.E. (1993).
Inhibition of kinesin synthesis and rapid anterograde axonal trans-
port in vivo by an antisense oligonucleotide. J. Biol. Chem. 268,
17427–17430.
Bloom, G.S., Richards, B.W., Leopold, P.L., Ritchey, D.M., and
Brady, S.T. (1993). GTP gamma S inhibits organelle transport along
axonal microtubules. J. Cell Biol. 120, 467–476.
Bradke, F., and Dotti, C.G. (1997). Neuronal polarity: vectorial cy-
toplasmic flow precedes axon formation. Neuron 19, 1175–1186.
Brady, S.T. (1985). A novel brain ATPase with properties expected
for the fast axonal transport motor. Nature 317, 73–75.
Brady, S.T., Pfister, K.K., and Bloom, G.S. (1990). A monoclonal
antibody against kinesin inhibits both anterograde and retrograde
fast axonal transport in squid axoplasm. Proc. Natl. Acad. Sci. USA
87, 1061–1065.
Bridgman, P.C. (1999). Myosin Va movements in normal and dilute-
lethal axons provide support for a dual filament motor complex.
J. Cell Biol. 146, 1045–1060.
Buxbaum, J.D., Thinakaran, G., Koliatsos, V., O’Callahan, J., Slunt,
H.H., Price, D.L., and Sisodia, S.S. (1998). Alzheimer amyloid pro-
tein precursor in the rat hippocampus: transport and processing
through the perforant path. J. Neurosci. 18, 9629–9637.
Craig, A.M., and Banker, G. (1994). Neuronal polarity. Annu. Rev.
Neurosci. 17, 267–310.
de Hoop, M.J., Meyn, L., and Dotti, C.G. (1998). Culturing hip-
pocampal neurons and astrocytes from fetal rodent brain. In: Cell
Biology: A Laboratory Handbook, ed. J.E. Celis, San Diego: Aca-
demic Press, 154–163.
Dotti, C.G., Sullivan, C.A., and Banker, G.A. (1988). The establish-
ment of polarity by hippocampal neurons in culture. J. Neurosci. 8,
1454–1468.
Ellenberg, J., Lippincott, S.J., and Presley, J.F. (1999). Dual-color
imaging with GFP variants. Trends Cell Biol. 9, 52–56.
Ferreira, A., Caceres, A., and Kosik, K.S. (1993). Intraneuronal com-
partments of the amyloid precursor protein. J. Neurosci. 13, 3112–
3123.
Ferreira, A., Niclas, J., Vale, R.D., Banker, G., and Kosik, K.S. (1992).
Suppression of kinesin expression in cultured hippocampal neurons
using antisense oligonucleotides. J. Cell Biol. 117, 595–606.
Hardy, J. (1997). Amyloid, the presenilins and Alzheimer’s disease.
Trends Neurosci. 20, 154–159.
Hirokawa, N. (1997). The mechanisms of fast and slow transport in
neurons: identification and characterization of the new kinesin su-
perfamily motors. Curr. Opin. Neurobiol. 7, 605–614.
Hirokawa, N. (1998). Kinesin and dynein superfamily proteins and
the mechanism of organelle transport. Science 279, 519–526.
Hirokawa, N., Noda, Y., and Okada, Y. (1998). Kinesin and dynein
superfamily proteins in organelle transport and cell division. Curr.
Opin. Cell Biol. 10, 60–73.
Hirschberg, K., Miller, C.M., Ellenberg, J., Presley, J.F., Siggia, E.D.,
Phair, R.D., and Lippincott, S.J. (1998). Kinetic analysis of secretory
protein traffic and characterization of Golgi to plasma membrane
transport intermediates in living cells. J. Cell Biol. 143, 1485–1503.
Ko¨hrmann, M., Luo, M., Kaether, C., DesGroseillers, L., Dotti, C.G.,
and Kiebler, M.A. (1999). Microtubule-dependent recruitment of
Staufen-green fluorescent protein into large RNA-containing gran-
ules and subsequent dendritic transport in living hippocampal neu-
rons. Mol. Biol. Cell 10, 2945–2953.
Koo, E.H., Sisodia, S.S., Archer, D.R., Martin, L.J., Weidemann, A.,
Beyreuther, K., Fischer, P., Masters, C.L., and Price, D.L. (1990).
Precursor of amyloid protein in Alzheimer disease undergoes fast
anterograde axonal transport. Proc. Natl. Acad. Sci. USA 87, 1561–
1565.
Kreis, T.E., Matteoni, R., Hollinshead, M., and Tooze, J. (1989).
Secretory granules and endosomes show saltatory movement bi-
ased to the anterograde and retrograde directions, respectively,
along microtubules in AtT20 cells. Eur. J. Cell Biol. 49, 128–139.
Leube, R.E., et al. (1987). Synaptophysin: molecular organization
and mRNA expression as determined from cloned cDNA. EMBO J.
6, 3261–3268.
Lochner, J.E., Kingma, M., Kuhn, S., Meliza, C.D., Cutler, B., and
Scalettar, B.A. (1998). Real-time imaging of the axonal transport of
granules containing a tissue plasminogen activator/green fluores-
cent protein hybrid. Mol. Biol. Cell 9, 2463–2476.
Morris, R.L., and Hollenbeck, P.J. (1995). Axonal transport of mito-
chondria along microtubules and F-actin in living vertebrate neu-
rons. J. Cell Biol. 131, 1315–1326.
Muresan, V., Godek, C.P., Reese, T.S., and Schnapp, B.J. (1996).
Plus-end motors override minus-end motors during transport of
squid axon vesicles on microtubules. J. Cell Biol. 135, 383–397.
Nakata, T., Terada, S., and Hirokawa, N. (1998). Visualization of the
dynamics of synaptic vesicle and plasma membrane proteins in
living axons. J. Cell Biol. 140, 659–674.
Noda, Y., Sato, Y.R., Kondo, S., Nangaku, M., and Hirokawa, N.
(1995). KIF2 is a new microtubule-based anterograde motor that
transports membranous organelles distinct from those carried by
kinesin heavy chain or KIF3A/B. J. Cell Biol. 129, 157–167.
Ochs, S. (1972). Fast transport of materials in mammalian nerve
fibers. Science 176, 252–260.
Okada, Y., Yamazaki, H., Sekine, A.Y., and Hirokawa, N. (1995). The
neuron-specific kinesin superfamily protein KIF1A is a unique mo-
Axonal Transport of GFP-tagged Proteins
Vol. 11, April 2000 1223
nomeric motor for anterograde axonal transport of synaptic vesicle
precursors. Cell 81, 769–780.
Pepperkok, R., Squire, A., Geley, S., and Bastiaens, P.I. (1999). Si-
multaneous detection of multiple green fluorescent proteins in live
cells by fluorescence lifetime imaging microscopy. Curr. Biol. 9,
269–272.
Prekeris, R., Foletti, D.L., and Scheller, R.H. (1999). Dynamics of
tubulovesicular recycling endosomes in hippocampal neurons.
J. Neurosci. 19, 10324–10337.
Selkoe, D.J. (1999). Translating cell biology into therapeutic ad-
vances in Alzheimer’s disease. Nature 399, A23–A31.
Simons, M., Ikonen, E., Tienari, P.J., Cid, A.A., Monning, U.,
Beyreuther, K., and Dotti, C.G. (1995). Intracellular routing of hu-
man amyloid protein precursor: axonal delivery followed by trans-
port to the dendrites. J. Neurosci. Res. 41, 121–128.
Storey, E., Katz, M., Brickman, Y., Beyreuther, K., and Masters, C.L.
(1999). Amyloid precursor protein of Alzheimer’s disease: evidence
for a stable, full-length, trans-membrane pool in primary neuronal
cultures. Eur. J. Neurosci. 11, 1779–1788.
Stowell, J.N., and Craig, A.M. (1999). Axon/dendrite targeting of
metabotropic glutamate receptors by their cytoplasmic carboxy-
terminal domains (see comments). Neuron 22, 525–536.
Toomre, D., Keller, P., White, J., Olivo, J.C., and Simons, K. (1999).
Dual-color visualization of trans-Golgi network to plasma mem-
brane traffic along microtubules in living cells. J. Cell Sci. 112, 21–33.
Vale, R.D., Reese, T.S., and Sheetz, M.P. (1985a). Identification of a
novel force-generating protein, kinesin, involved in microtubule-
based motility. Cell 42, 39–50.
Vale, R.D., Schnapp, B.J., Reese, T.S., and Sheetz, M.P. (1985b).
Movement of organelles along filaments dissociated from the axo-
plasm of the squid giant axon. Cell 40, 449–454.
Wacker, I., Kaether, C., Kro¨mer, A., Migala, A., Almers, W., and
Gerdes, H.-H. (1997). Microtubule-dependent transport of secretory
vesicles visualized in real time with a GFP-tagged secretory protein.
J. Cell Sci. 110, 1453–1463.
Weidemann, A., Konig, G., Bunke, D., Fischer, P., Salbaum, J.M.,
Masters, C.L., and Beyreuther, K. (1989). Identification, biogenesis,
and localization of precursors of Alzheimer’s disease A4 amyloid
protein. Cell 57, 115–126.
Wessel, D., and Flu¨gge, U.I. (1984). A method for quantitative
recovery of protein in dilute solution in the presence of detergent
and lipids. Anal. Biochem. 138, 141–143.
Winckler, B., and Mellman, I. (1999). Neuronal polarity: controlling
the sorting and diffusion of membrane components (in process
citation). Neuron 23, 637–640.
Yamazaki, T., Selkoe, D., and Koo, E.H. (1995). Trafficking of cell
surface b-amyloid precursor protein: retrograde and transcytotic
transport in cultured neurons. J. Cell Biol. 129, 431–442.
Yonekawa, Y., Harada, A., Okada, Y., Funakoshi, T., Kanai, Y.,
Takei, Y., Terada, S., Noda, T., and Hirokawa, N. (1998). Defect in
synaptic vesicle precursor transport and neuronal cell death in
KIF1A motor protein-deficient mice. J. Cell Biol. 141, 431–441.
Zakharenko, S., and Popov, S. (1998). Dynamics of axonal microtu-
bules regulate the topology of new membrane insertion into the
growing neurites. J. Cell Biol. 143, 1077–1086.
C. Kaether et al.
Molecular Biology of the Cell1224
